Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis  Bernard Grenier  Clinical.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Benchmarking inappropriate empirical antibiotic treatment
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Classification and criteria of otitis media
Approach to diagnosis of infective endocarditis
E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H
Herpes zoster in non-hospitalized children
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Bernard Grenier  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media  Fernando Baquero, Rafael Cantón, Fernando.
Antibacterial drug discovery: is it all downhill from here?
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
P. Davey, C. Pagliari, A. Hayes  Clinical Microbiology and Infection 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription  B. Maraha, M. Bonten, H. Fiolet,
Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca  N. Moustaoui,
Structure of grepafloxacin relative to activity and safety profile
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
The antibacterial effects of ciprofloxacin and trovafloxacin against Streptococcus pneumoniae in an in vitro dynamic model  Matthew O'Brien, Thuy Quach,
B. Gordts  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H
Uncommon opportunistic fungi: new nosocomial threats
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
A. Bryskier  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Antibacterial drug discovery in the 21st century
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Benchmarking inappropriate empirical antibiotic treatment
Training in infectious diseases and tropical medicine in Britain
Current experience in treating invasive zygomycosis with posaconazole
Reducing antibiotic use in influenza: challenges and rewards
Antimicrobial drug development – the past, the present, and the future
Definition of the Clinical Antibacterial Spectrum of Activity
Clinical infection services—the Leiden experience
Ethan Rubinstein, Itzhak Levy  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Empiric therapy of bacterial infections in severe neutropenia
W. Eugene Sanders, Christine C. Sanders 
Overview of cefixime use in community-acquired infections
A. Norberg, C.E. Nord, B. Evengård  Clinical Microbiology and Infection 
Sanford Chodosh  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
Carratalà J.   Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Abstracts Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis  Bernard Grenier  Clinical Microbiology and Infection  Volume 3, Pages 3S62-3S68 (January 1997) DOI: 10.1016/S1198-743X(14)64957-0 Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Probability tree of clinical success rate observed in relation to an antibacterial effect of the prescribed antibiotic drug. Clinical Microbiology and Infection 1997 3, 3S62-3S68DOI: (10.1016/S1198-743X(14)64957-0) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Regressionline of clinical efficacy on antibacterial activity of antibiotic treatment. Along the identity brokenline, the clinical success rate is equal to the antibacterial activity or bacterial success rate. Clinical Microbiology and Infection 1997 3, 3S62-3S68DOI: (10.1016/S1198-743X(14)64957-0) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions